,i  #aae? ,,congress  #b;d ,session  ,h4
 ,r4 #feic  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,july #bf1 #bjah ,mr4 
,duncan ( ,t5nessee introduc$ ! foll[+  
bill2 :i* 0 ref]r$ to ! ,committee on   
,en]gy & ,comm]ce  ,a ,,bill  ,to direct
 ! ,comptroll] ,g5]al ( ! ,unit$ ,/ates 
to conduct a /udy on ! feasibility (    
e/abli%+ & ma9ta9+ an automat$ &        
se>*able sy/em t tracks prescription    
drug prices 9 ! ,unit$ ,/ates1 & = o!r  
purposes4  #a4 ,%ort title ,?is ,act may
 be cit$ z ! ,m$ication ,automat$       
,quotation ,sy/em1 or ,,m$aq1 ,act (    
#bjah4  #b4 ,/udy on ! feasibility (    
creat+ a sy/em t tracks prescription    
drug co/s  7a7 ,/udy ,! ,comptroll]     
,g5]al ( ! ,unit$ ,/ates1 9 consultation
 ) ! ,commission] ( ,food & ,drugs & !  
,adm9i/rator ( ,,cms1 %all conduct a    
/udy on ! feasibility ( e/abli%+ a      
m$ication automat$ quotation sy/em4  7b7
 ,elem5ts ,! feasibility /udy requir$ "u
 subsection 7a7 %all include assessm5ts 
( ! foll[+3 7#a7 ,! feasibility (--     

7,a7 collect+ or compil+ data on !      
acquisition price p] unit t any pur*as] 
7includ+ b n limit$ to a di/ributor1 a  
retail]1 a ?ird-p>ty payor1 or ultimate 
consum]7 pays = a prescription drug & ! 
effect ,p,b,ms & o!r involv$ entities h 
on su* prices2 &  7,b7 aggregat+ su*    
data 9 a mann] t does n reveal p]sonally
 id5tifiable in=mation4  7#b7 ,! co/ (  
procur+ & ma9ta9+ a m$ication automat$  
quotation sy/em1 or ,,m$aq1 bas$ on !   
above data4  7#c7 ,! ne$ = new or       
additional laws1 regulations1 or        
policies to collect ! data necess>y = a 
m$ication automat$ quotation sy/em to   
track & g5]ate prescription drug pric+  
data 9 ! ,unit$ ,/ates4  7#d7 ,!        
possibility ( integrat+ or us+ ! ,,fda's
 ,,ndc sy/em & ,,cms ,,nadac :5 creat+ !
 ,,m$aq4  7#e7 ,integration ( ,,cms     
,,nadac :5 creat+ ! ,,m$aq &1 n )/&+ any
 o!r provision ( ?is ,act1 %all n       
consid] ph>macy report+1 collect+1 or   
compil+ requirem5ts beyond or 9 addition
 to ! requirem5ts ( ,,cms ,,nadac4  7#f7

 ,:e!r ! sy/em describ$ "u subsection   
7a7 is likely to be effective 9 r$uc+   
ov]all prescription drug prices by      
increas+ competition & transp>5cy 9 !   
drug indu/ry4  7c7 ,report ,n lat] ?an  
#bgj days aft] ! date ( ! enactm5t ( ?is
 ,act1 ! ,comptroll] ,g5]al %all submit 
to ,congress a report on ! results ( !  
/udy conduct$ "u subsection 7a74  7d7   
,m$ication automat$ quotation sy/em     
def9$ ,! t]m m$ication automat$         
quotation sy/em or ,,m$aq means an      
automat$ & se>*able sy/em t-- 7#a7 )    
respect to ! ,unit$ ,/ates 7& ) respect 
to ea* region !re(71 tracks & g5]ates   
data on ! acquisition price p] unit (   
any prescription drug t a pur*as] pays =
 su* unit ( su* drug2  7#b7 produces    
reports 9 real "t on av]age prices p]   
unit & o!r data2 &  7#c7 is accessible  
to pur*as]s1 :o h paid a us] fee1 )     
limitations to ensure appropriate       
privacy b also transp>5cy 9 price       
negotiations4